title: Valproate-induced hepatoxicity: protective effect of L-carnitine supplementation.
authors: Department of Pediatrics, Kansai Medical University, Otokoyama Hospital, Kyoto.
authors: T
authors: T
authors: Sugimoto
authors: N
authors: N
authors: Nishida
authors: K
authors: K
authors: Murakami
authors: M
authors: M
authors: Woo
authors: Y
authors: Y
authors: Sakane
authors: A
authors: A
authors: Yasuhara
authors: H
authors: H
authors: Shuto
authors: T
authors: T
authors: Hatanaka
authors: Y
authors: Y
authors: Kobayashi
mesh_terms: D000927:Anticonvulsants / Q000008:administration & dosage; D002331:Carnitine / Q000008:administration & dosage*; D056486:Chemical and Drug Induced Liver Injury / Q000517:prevention & control*; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007223:Infant; D008111:Liver Function Tests; D008297:Male; D011502:Protein-Energy Malnutrition / Q000150:complications; D012307:Risk Factors; D014635:Valproic Acid / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000927:Anticonvulsants; D014635:Valproic Acid; D002331:Carnitine